Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AMGEN INC | 130,488 | reported | 29 Apr 2010 | tx 32+590,915.43−369,796 |
| Otonomy, Inc. | 15,000 | reported | 20 Jun 2017 | tx 3+55,000 |
| VICAL INC | 6,500 | reported | 23 May 2018 | tx 11+281,241 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 27+195,414−120,386 |
| SAFEWAY INC | 0 | reported | 30 Jan 2015 | tx 18+12,233.18−10,659.69 |
| ALIGN TECHNOLOGY INC | 0 | reported | 20 May 2026 | tx 99+371,618−363,309 |
| HUMAN GENOME SCIENCES INC | 0 | reported | 30 Jul 2012 | tx 9+72,000−31,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 20 May 2026 | EXERCISE | ALIGN TECHNOLOGY INC | 1,745 | 0.00 USD | |
| 20 May 2026 | EXERCISE | ALIGN TECHNOLOGY INC | 1,745 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 25 Nov 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 15,000 | 143.37 USD | |
| 25 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 47.89 USD | |
| 25 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 15,000 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 21 May 2025 | EXERCISE | ALIGN TECHNOLOGY INC | 1,148 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | ALIGN TECHNOLOGY INC | 1,745 | 0.00 USD | deriv |
| 21 May 2025 | EXERCISE | ALIGN TECHNOLOGY INC | 1,148 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | ALIGN TECHNOLOGY INC | 1,148 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | |
| 17 May 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 4,199 | 0.00 USD | deriv |
| 17 May 2024 | EXERCISE | ALIGN TECHNOLOGY INC | 1,029 | 0.00 USD | |
| 17 May 2024 | EXERCISE | ALIGN TECHNOLOGY INC | 1,029 | 0.00 USD | deriv |
| 14 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 20,000 | 39.79 USD | |
| 14 Mar 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 20,000 | 139.41 USD | |
| 14 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 20,000 | 39.79 USD | |
| 14 Mar 2024 | SALE | NEUROCRINE BIOSCIENCES INC | 20,000 | 139.42 USD | |
| 14 Mar 2024 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 20,000 | 39.79 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 15 Oct 2012.